O'Brien Greene & Co. Inc P Lx Pharma Inc. Transaction History
O'Brien Greene & Co. Inc
- $305 Million
- Q3 2024
A detailed history of O'Brien Greene & Co. Inc transactions in P Lx Pharma Inc. stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 27,000 shares of PLXP stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,000
Previous 27,000
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PLXP
# of Institutions
6Shares Held
62.7KCall Options Held
0Put Options Held
0-
Eidelman Virant Capital27KShares$00.01% of portfolio
-
Exane Derivatives6.58KShares$00.01% of portfolio
-
Financial Gravity Asset Management, Inc.1.05KShares$00.0% of portfolio
-
Financial Gravity Companies, Inc. Lakeway, TX1.05KShares$00.0% of portfolio
-
Tucker Asset Management LLC Littleton, CO25Shares$00.0% of portfolio
About PLx Pharma Inc.
- Ticker PLXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,137,700
- Description
- PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...